ACA
HAE icon

Anchor Capital Advisors’s Haemonetics HAE Stock Holding History

Anchor Capital Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-127,147
Closed -$8.47M – 271
2021
Q2 		$8.47M Sell
127,147
-285,071
-69% -$20.2M 0.17% 105
2021
Q1 		$45.8M Sell
412,218
-34,517
-8% -$4.27M 0.97% 48
2020
Q4 		$53M Sell
446,735
-17,530
-4% -$1.89M 1.21% 29
2020
Q3 		$40.5M Buy
+464,265
New +$40.6M 1.03% 37
2018
Q3 		– Sell
-324,102
Closed -$29.1M – 275
2018
Q2 		$29.1M Sell
324,102
-377,870
-54% -$31.9M 1.07% 28
2018
Q1 		$51.4M Sell
701,972
-42,592
-6% -$2.92M 1.79% 7
2017
Q4 		$43.2M Sell
744,564
-17,387
-2% -$916K 1.53% 13
2017
Q3 		$34.2M Sell
761,951
-12,955
-2% -$538K 1.23% 21
2017
Q2 		$30.6M Buy
774,906
+227,941
+42% +$9.36M 1.12% 26
2017
Q1 		$22.2M Buy
546,965
+169,850
+45% +$6.63M 0.77% 59
2016
Q4 		$15.2M Sell
377,115
-204,868
-35% -$7.72M 0.58% 77
2016
Q3 		$21.1M Sell
581,983
-323,483
-36% -$11.1M 0.71% 59
2016
Q2 		$26.2M Sell
905,466
-5,768
-0.6% -$174K 0.67% 63
2016
Q1 		$31.9M Buy
911,234
+15,275
+2% +$493K 0.76% 54
2015
Q4 		$28.9M Sell
895,959
-28,880
-3% -$937K 0.73% 61
2015
Q3 		$29.9M Sell
924,839
-9,912
-1% -$373K 0.76% 58
2015
Q2 		$38.7M Sell
934,751
-16,682
-2% -$703K 0.87% 45
2015
Q1 		$42.7M Sell
951,433
-66,892
-7% -$2.8M 0.93% 40
2014
Q4 		$38.1M Sell
1,018,325
-32,728
-3% -$1.2M 0.77% 52
2014
Q3 		$36.7M Sell
1,051,053
-65,023
-6% -$2.32M 0.76% 52
2014
Q2 		$39.4M Sell
1,116,076
-2,984
-0.3% -$99.7K 0.76% 52
2014
Q1 		$36.5M Buy
1,119,060
+6,700
+0.6% +$256K 0.73% 54
2013
Q4 		$46.9M Sell
1,112,360
-35,873
-3% -$1.48M 0.93% 40
2013
Q3 		$45.8M Sell
1,148,233
-62,115
-5% -$2.61M 0.99% 42
2013
Q2 		$50M Buy
+1,210,348
New +$49M 1.07% 42

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Anchor Capital Advisors's HAE Position: Q3 2021 in Review

Anchor Capital Advisors sold out of Haemonetics (HAE) in Q3 2021, closing a stake of 127,147 shares — an estimated $8.47M sold.

Anchor Capital Advisors first reported a position in HAE in Q2 2013 and held it in 25 quarters. The position peaked at $53M in Q4 2020. 245 funds tracked by Wall St. Rank hold HAE as of Q3 2021.

  • Anchor Capital Advisors reported no remaining Haemonetics position as of Q3 2021 after selling out during the quarter.
  • Anchor Capital Advisors sold 127,147 Haemonetics shares in Q3 2021, an estimated $8.47M.
  • Anchor Capital Advisors first reported a position in Haemonetics in Q2 2013 and held it in 25 quarters.
  • Anchor Capital Advisors's Haemonetics position peaked at $53M in Q4 2020.
  • 245 funds tracked by Wall St. Rank held Haemonetics as of Q3 2021.

Based on Anchor Capital Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.